An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)
- PMID: 28118673
- DOI: 10.1055/s-0043-100934
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)
Abstract
This review summarizes published in vitro, animal, and clinical studies investigating the effects of green tea (Camellia sinensis) extract and associated catechins on drug-metabolizing enzymes and drug transporters. In vitro studies suggest that green tea extract and its main catechin, (-)-epigallocatechin-3-gallate, to varying degrees, inhibit the activity of CYP1A1, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2D6, and CYP3A4. UGT1A1 and UGT1A4 isoforms were also inhibited by (-)-epigallocatechin-3-gallate. Animal studies suggest green tea extract and/or (-)-epigallocatechin-3-gallate significantly increase the bioavailability of diltazem, verapamil, tamoxifen simvastatin, 5-fluorouracil, and nicardipine. Conversely, green tea extract and/or (-)-epigallocatechin-3-gallate reduce the bioavailability of quetiapine, sunitinib, clozapine, and nadolol. Of the few clinical studies available for review, it appears neither green tea extract nor (-)-epigallocatechin-3-gallate inhibit any major cytochrome P450 enzyme. Regarding drug transporters, in vitro studies indicate P-glycoprotein, organic anion transporting polypeptide 1A1, organic anion transporting polypeptide 1B1, organic anion transporting polypeptide 1B3, organic anion transporting polypeptide 2B1, organic cation transporter 1, organic cation transporter 2, multidrug and toxin extrusion 1, and multidrug and toxin extrusion 2-K are potentially inhibited by green tea extract. A clinical study indicates the organic anion transporting polypeptide 1A1 transporter is inhibited by (-)-epigallocatechin-3-gallate while P-glycoprotein is unaffected. In conclusion, the ingestion of green tea extract or its associated catechins is not expected to result in clinically significant influences on major cytochrome P450 or uridine 5'-diphospho-glucuronosyltransferase enzyme substrates or drugs serving as substrates of P-glycoprotein. However, some caution is advised in the consumption of significant amounts of green tea beverages or green tea extract in patients prescribed known substrates of organic anion transporting polypeptide, particularly those with a narrow therapeutic index.
Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.Phytomedicine. 2013 Nov 15;20(14):1247-50. doi: 10.1016/j.phymed.2013.07.003. Epub 2013 Aug 3. Phytomedicine. 2013. PMID: 23920278
-
Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.PLoS One. 2015 Oct 1;10(10):e0139370. doi: 10.1371/journal.pone.0139370. eCollection 2015. PLoS One. 2015. PMID: 26426900 Free PMC article.
-
Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activities.J Pharm Pharm Sci. 2016 Apr-Jun;19(2):188-97. doi: 10.18433/J3MS5C. J Pharm Pharm Sci. 2016. PMID: 27518169 Review.
-
Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.Eur J Clin Pharmacol. 2018 Jun;74(6):775-783. doi: 10.1007/s00228-018-2436-2. Epub 2018 Feb 26. Eur J Clin Pharmacol. 2018. PMID: 29480324 Clinical Trial.
-
Green tea (Camellia sinensis) catechins and vascular function.Br J Nutr. 2009 Dec;102(12):1790-802. doi: 10.1017/S0007114509991218. Br J Nutr. 2009. PMID: 19751534 Review.
Cited by
-
Flavonoids as CYP3A4 Inhibitors In Vitro.Biomedicines. 2024 Mar 13;12(3):644. doi: 10.3390/biomedicines12030644. Biomedicines. 2024. PMID: 38540257 Free PMC article. Review.
-
Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in Mice.Pharm Res. 2024 Mar;41(3):557-566. doi: 10.1007/s11095-024-03662-w. Epub 2024 Feb 1. Pharm Res. 2024. PMID: 38302834
-
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase.Front Pharmacol. 2024 Jan 11;14:1231671. doi: 10.3389/fphar.2023.1231671. eCollection 2023. Front Pharmacol. 2024. PMID: 38273823 Free PMC article.
-
The Use of an Antioxidant Enables Accurate Evaluation of the Interaction of Curcumin on Organic Anion-Transporting Polypeptides 4C1 by Preventing Auto-Oxidation.Int J Mol Sci. 2024 Jan 12;25(2):991. doi: 10.3390/ijms25020991. Int J Mol Sci. 2024. PMID: 38256064 Free PMC article.
-
Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants.Clin Transl Sci. 2023 Oct;16(10):1779-1790. doi: 10.1111/cts.13578. Epub 2023 Aug 28. Clin Transl Sci. 2023. PMID: 37639334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical